ClinicalTrials.Veeva

Menu

Graves' Orbitopathy and Hypercholesterolemia (GOCol)

U

University of Pisa

Status

Completed

Conditions

Graves' Ophthalmopathy
Hypercholesterolemia

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The investigators have recently observed retrospectively that the occurrence of Graves' Orbitopathy in patients with Graves' disease is less frequent in patients with normal cholesterol levels, in line with another recent observation suggesting that statins play a protective role in Graves' patients from developing Graves' Orbitopathy. The present study is designed in order to investigate the possible association between Graves' Orbitopathy and high cholesterol level as well as the relation between Graves' Orbitopathy degree and high cholesterol level

Enrollment

250 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Graves' disease with Graves' Orbitopathy
  2. Graves' disease without Graves' Orbitopathy

Exclusion criteria

  1. Previous treatment with radioiodine
  2. Previous treatment with thyroidectomy

Trial design

250 participants in 2 patient groups

Graves' Disease
Description:
Patients with Graves' disease, without Graves' Orbitopathy
Treatment:
Other: No intervention
Graves' Orbitopathy
Description:
Patients with Graves' disease, with Graves' Orbitopathy
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems